SoftMedx Healthcare Limited will convene its board of directors on Monday, 10 August 2026 to consider and approve the publication of the unaudited interim results for the six-month period ended 30 June 2026.
The meeting agenda centres on releasing the consolidated performance of the Company and its subsidiaries for the first half of 2026.
Board composition as at the 29 July 2026 announcement date comprises one executive director, Mr. Lin Pinzhuo, and three independent non-executive directors: Mr. Ngok Ho Wai, Ms. Tang Cuihuen and Mr. Yiu Chun Wing. Company Secretary Mr. Lam Sung Him Gaston issued the notice from Hong Kong.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments